BridgeBio Pharma, Inc.
BBIOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How BridgeBio Pharma, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| SEI INVESTMENTS CO | 2026-03-31 | 288,075 | $21.4M | SEC filing |
| Vestmark Advisory Solutions, Inc. | 2026-03-31 | 11,050 | $821K | SEC filing |
| SMA Capital LLC | 2026-03-31 | 353 | $26.2K | SEC filing |
| Compound Planning, Inc. | 2026-03-31 | 2,739 | $203K | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 20,600 | $1.53M | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 1,248,521 | $92.7M | SEC filing |
| Optiver Holding B.V. | 2026-03-31 | 489 | $36.3K | SEC filing |
| E Fund Management Co., Ltd. | 2026-03-31 | 8,162 | $606K | SEC filing |
| Harvest Fund Management Co., Ltd | 2026-03-31 | 938 | Not shown | SEC filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2026-03-31 | 599,000 | $44.5M | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 1,908,907 | $146M | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 7,142 | $530K | SEC filing |
| FIRST HORIZON CORP | 2026-03-31 | 1,452 | $108K | SEC filing |
| Sound Income Strategies, LLC | 2026-03-31 | 178 | $13.3K | SEC filing |
| WPG Advisers, LLC | 2026-03-31 | 161 | $12K | SEC filing |
| Homestead Advisers Corp | 2026-03-31 | 5,900 | $438K | SEC filing |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 2026-03-31 | 15,637 | Not shown | SEC filing |
| Swiss Life Asset Management Ltd | 2026-03-31 | 8,906 | $661K | SEC filing |
| SECTOR GAMMA AS | 2026-03-31 | 44,263 | $3.29M | SEC filing |
| STIFEL FINANCIAL CORP | 2026-03-31 | 4,573 | $340K | SEC filing |
- Each value is checked against BridgeBio Pharma, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at BridgeBio Pharma, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among BridgeBio Pharma, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-24 · Cook Jennifer E.: Larger than 148 of the 155 other insider sales of Common Stock on file. SEC filing
- 2026-06-15 · Cook Jennifer E.: Larger than 154 of the 155 other insider sales of Common Stock on file. SEC filing
- 2026-03-04 · Ellis Andrea: Larger than 152 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-12-15 · Kumar Neil: Larger than 144 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-11-18 · Lo Andrew: Larger than 145 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-11-18 · Lo Andrew: Larger than 141 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · Lo Andrew: Larger than 147 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-11-12 · Valantine Hannah: Larger than 142 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-11-06 · DANIELS RONALD J: Larger than 151 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · MCCORMICK FRANK: Larger than all 155 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · MCCORMICK FRANK: Larger than 146 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · MCCORMICK FRANK: Larger than 150 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-09-05 · MCCORMICK FRANK: Larger than 153 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-08-21 · Trimarchi Thomas: Larger than 149 of the 155 other insider sales of Common Stock on file. SEC filing
- 2025-08-20 · Kumar Neil: Larger than 143 of the 155 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-24 | Cook Jennifer E. · Director | Common Stock | S — Open market or private sale | −37,167 | 70.00 | SEC filing |
| 2026-06-23 | Cook Jennifer E. · Director | Common Stock | S — Open market or private sale | −2,196 | 68.57 | SEC filing |
| 2026-06-23 | Valantine Hannah · Director | Common Stock | S — Open market or private sale | −2,196 | 68.57 | SEC filing |
| 2026-06-22 | Valantine Hannah · Director | Common Stock | S — Open market or private sale | −2,808 | 68.00 | SEC filing |
| 2026-06-15 | Cook Jennifer E. · Director | Common Stock | S — Open market or private sale | −88,737 | 66.62 | SEC filing |
| 2026-06-15 | Cook Jennifer E. · Director | Common Stock | S — Open market or private sale | −1,503 | 67.14 | SEC filing |
| 2026-06-05 | Kumar Neil · Chief Executive Officer | Common Stock | S — Open market or private sale | −7,147 | 67.20 | SEC filing |
| 2026-06-05 | Kumar Neil · Chief Executive Officer | Common Stock | S — Open market or private sale | −4,415 | 68.96 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-24 | Cook Jennifer E. · Director | Common Stock | M — Exercise or conversion of derivative security | +20,000 | SEC filing |
| 2026-06-24 | Cook Jennifer E. · Director | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −17,167 | SEC filing |
| 2026-06-24 | Cook Jennifer E. · Director | Common Stock | M — Exercise or conversion of derivative security | +17,167 | SEC filing |
| 2026-06-24 | Cook Jennifer E. · Director | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −20,000 | SEC filing |
| 2026-06-22 | Valantine Hannah · Director | Common Stock | M — Exercise or conversion of derivative security | +2,808 | SEC filing |
| 2026-06-22 | Valantine Hannah · Director | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −2,808 | SEC filing |
| 2026-06-22 | MCCORMICK FRANK · Director | Common Stock | A — Grant, award, or other acquisition | +3,990 | SEC filing |
| 2026-06-22 | Ellis Andrea · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +5,277 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.